Profile
Corporate information
Official name
Blossomhill Therapeutics, Inc.
Registration country
Investment activity status
Active investor
Company type
Biotechnology company focused on oncology and autoimmune disorders.Funding
Funding rounds
Series A USD 71,000,000
USD 71,000,000 (4 Mar 2021)
Investor | Profile | Country | Notes | |
---|---|---|---|---|
![]() |
Cormorant Asset Management LLC | Initial investment. Led the round. | ||
![]() |
Hercules BioVentures | Initial investment. Round participant. | ||
![]() |
OrbiMed Advisors LLC | American investment firm focused on making public and private investments in the healthcare and biotechnology industries. | United States | Initial investment. Round participant. |
![]() |
Vivo Capital LLC | Initial investment. Round participant. |
Cap Table
Current and past shareholders
Investor | Contacts | Round | |
---|---|---|---|
![]() |
Cormorant Asset Management LLC |
Series A | |
![]() |
Hercules BioVentures |
Series A | |
![]() |
OrbiMed Advisors LLC American investment firm focused on making public and private investments in the healthcare and biotechnology industries. |
+1 (212) 739-6400 |
Series A |
![]() |
Vivo Capital LLC |
Series A |